- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 31, 2025 | 12.78M sh |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $20.66M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $30.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.41M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $6.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $16.89M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $17.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $17.23M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $17.57M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $95.09M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $89.37M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $159.94M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $152.19M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 13.46M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $0 |
| Capex | Q1 2025 · Dec 31, 2023 | $779K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $2.65M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $146.31M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $132.72M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.94 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.96 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $5.83M |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $3.6M |
| Net Income | Q1 2025 · Dec 31, 2023 | $12.68M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $12.84M |
| Gross Profit | Q1 2025 · Dec 31, 2023 | $22.24M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $27.8M |
| Revenue | Q1 2025 · Dec 31, 2023 | $50.03M |